Dr. Robin Avery is an infectious disease physician who joined the Johns Hopkins faculty in 2012, with two decades of experience in transplant infectious disease. She is a past chair of the American Society of Transplantation (AST) Infectious Disease Community of Practice, was a co-editor of the first edition of the AST ID Guidelines, and serves on a Guidelines Committee for the Infectious Disease Society of America (IDSA) on immunizations in the immunocompromised host. She was the founding head of the Transplant Infectious Disease Section at the Cleveland Clinic and served as the founding director of the Cleveland Clinic Transplant ID Special Fellowship, authoring a curriculum that served as the basis for curricula later endorsed by the AST and IDSA. Her clinical and research interests include pre-transplant donor and recipient evaluation, and prevention and treatment of post-transplant infections, particularly transplant-associated viruses, viral load monitoring, novel therapies for CMV, hypogammaglobulinemia, immunizations, and strategies for safer living post-transplant. She has a strong interest in patient education and co-authored the script for a video designed to educate patients on decreasing post-transplant infection risks. Dr. Avery is rated as a Distinguished provider by MediFind in the treatment of Sepsis. Her top areas of expertise are Cytomegalic Inclusion Disease, Cytomegalovirus Infection, COVID-19, and Sepsis.

Eyad Cheikh, M.D. received his medical degree from the University of Damascus School of Medicine. He completed residency training in Internal Medicine at Saint Agnes Hospital in Baltimore, and finished his fellowship in Infectious Diseases at Carilion Clinic in Carilion Roanoke Memorial Hospital. Dr. Cheikh's areas of interest include general Infectious Diseases, HIV care and infection control. Learn more at idmaryland.com. Dr. Cheikh is rated as an Advanced provider by MediFind in the treatment of Sepsis. His top areas of expertise are Sepsis, Hospital-Acquired Pneumonia, Pneumonia, and Multisystem Inflammatory Syndrome in Children (MIS-C).

Dr. Sara Keller graduated from the Duke University School of Medicine in 2007. She completed her Master of Public Health in epidemiology in 2006 at the University of North Carolina at Chapel Hill. She then completed a residency in Internal Medicine in the Osler Medical Residency Training Program at the Johns Hopkins Hospital in 2010, a fellowship in Infectious Diseases at the University of Pennsylvania in 2012, and a fellowship in the University of Pennsylvania Centers for Healthcare Improvement and Patient Safety in 2013. She also completed a Master of Science in Health Policy at the University of Pennsylvania in 2013. She is an Assistant Professor in Infectious Diseases where she primarily sees patients at Johns Hopkins Green Spring Station and also attends on the inpatient infectious disease consult service at the Johns Hopkins Hospital. She serves as the Medical Director of the Johns Hopkins Hospital Outpatient Parenteral Antimicrobial Therapy (OPAT) Service. Dr. Keller is rated as an Advanced provider by MediFind in the treatment of Sepsis. Her top areas of expertise are Asymptomatic Bacteriuria, Sepsis, Severe Acute Respiratory Syndrome (SARS), and COVID-19.

John Baddley is an Infectious Disease provider in Baltimore, Maryland. Dr. Baddley is rated as a Distinguished provider by MediFind in the treatment of Sepsis. His top areas of expertise are Cryptococcosis, Shingles, Sepsis, and Febrile Neutropenia.

Dr. Aaron M. Milstone is a professor of pediatrics at the Johns Hopkins University School of Medicine. He holds a joint appointments in Epidemiology and Health Policy and Management at the Bloomberg School of Public Health. A pediatric epidemiologist, Dr. Milstone specializes in treating infectious diseases in children. He serves as an associate hospital epidemiologist at The Johns Hopkins Hospital and the pediatric lead for infection prevention for the Johns Hopkins Health System. Dr. Milstone earned his medical degree from Yale University School of Medicine. He completed both a pediatrics residency and a research fellowship in pediatric infectious diseases at Children's Hospital of Philadelphia. He also completed a pediatric infectious diseases fellowship at Johns Hopkins. He holds a M.H.S. (Graduate Training Program in Clinical Investigation) from the Johns Hopkins Bloomberg School of Public Health and Johns Hopkins University School of Medicine. Dr. Milstone joined the Johns Hopkins faculty in 2007. His research interests focus on antibiotic resistance and prevention of healthcare-associated infections. He had led numerous clinical trials including the Pediatric SCRUB Trial and TREAT PARENTS Trial testing strategies to prevent organism transmission and healthcare-associated infections. He is principal investigator of the BrighT STAR Collaborative, guiding hospitals nationwide to reduce over-testing as a strategy to reduce antibiotic use and resistance. Dr. Milstone is a fellow of the American Academy of Pediatrics, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society for Healthcare Epidemiology of America. His many other professional honors include the Pediatric Infectious Diseases Society’s 2014 Young Investigator Award, the inaugural 2013 Caroline B. Hall Clinical Innovation Award, and the Society for Healthcare Epidemiology of America 2018 Mentor Scholar Award, and 2023 Johns Hopkins Medicine Armstrong Award for Excellence in Quality & Safety. Dr. Milstone is rated as a Distinguished provider by MediFind in the treatment of Sepsis. His top areas of expertise are Sepsis, Methicillin-Resistant Staphylococcus Aureus (MRSA), Severe Acute Respiratory Syndrome (SARS), and Neonatal Sepsis.

Dr. Cosgrove is a Professor of Medicine in the Division of Infectious Disease (ID) at Johns Hopkins University School of Medicine and has a joint appointment in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health. She is the Director of Research for the ID Fellowship Program and PI of the T32 training grant that supports ID fellow training. She serves as the Director of the Department of Antimicrobial Stewardship and an Associate Hospital Epidemiologist at The Johns Hopkins Hospital. Dr. Cosgrove’s research interests include the epidemiology and outcomes of antimicrobial resistance, the development of tools and programs to promote the rational use of antimicrobials, the prevention of hospital-acquired infections, and the epidemiology and management of S. aureus bacteremia. Early in her career, she recognized the critical need to study antimicrobial stewardship strategies and has led a series of outcomes studies over the past 20 years that have defined the practice of antimicrobial stewardship in the United States. Her recent research focuses on strategies for implementation of antimicrobial stewardship activities across all healthcare settings via a large, multi-center project including hospitals, long-term care facilities and ambulatory practices funded by the Agency for Healthcare Research and Quality, and approaches to improve how antibiotics are given via a randomized trial to compare intravenous and oral therapy for Gram negative bacteremia funded by PCORI. She is the PI of the Johns Hopkins Prevention Epicenter, a Centers for Disease Control and Prevention-funded program that integrates antimicrobial stewardship, healthcare epidemiology, human factors engineering, data science, and implementation science to address knowledge gaps and develop strategies to optimize patient safety by preventing transmission of pathogens and improving antibiotic use in diverse healthcare settings and patient populations. She is a past voting member of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria. She is a Past President of the Society for Healthcare Epidemiology’s Board of Directors. Dr. Cosgrove received her undergraduate degree from Columbia College, her medical degree from Baylor College of Medicine, and her master of science degree in epidemiology from Harvard School of Public Health. She completed her postgraduate training in internal medicine at The Johns Hopkins Hospital and underwent subsequent training in ID at Beth Israel Deaconess Medical Center. Dr. Cosgrove is rated as a Distinguished provider by MediFind in the treatment of Sepsis. Her top areas of expertise are Sepsis, Methicillin-Resistant Staphylococcus Aureus (MRSA), Pneumonia, and Pseudomonas Stutzeri Infections.

Aneta Gramatikova is a primary care provider, practicing in Internal Medicine in Randallstown, Maryland. Dr. Gramatikova is rated as an Advanced provider by MediFind in the treatment of Sepsis. Her top areas of expertise are Cellulitis, Renovascular Hypertension, Hospital-Acquired Pneumonia, Gastrostomy, and Colonoscopy.

Ramaswamy Rangarajan is a primary care provider, practicing in Internal Medicine in Randallstown, Maryland. Dr. Rangarajan is rated as an Advanced provider by MediFind in the treatment of Sepsis. His top areas of expertise are Multisystem Inflammatory Syndrome in Children (MIS-C), COVID-19, Dehydration, Gastrostomy, and Colonoscopy.

Gerard Moawad is a primary care provider, practicing in Internal Medicine in Owings Mills, Maryland. Dr. Moawad is rated as an Advanced provider by MediFind in the treatment of Sepsis. His top areas of expertise are Sepsis, Atypical Pneumonia, Hospital-Acquired Pneumonia, Gastrostomy, and Endoscopy. Dr. Moawad is currently accepting new patients.

Robert Ross, M.D. received his medical degree from the Oregon Health and Science University in Portland, Oregon. He completed an Internal Medicine residency at the University of Maryland Medical System. Dr. Ross completed his training with an Infectious Diseases fellowship at the National Institutes of Health. While at the NIH, Dr. Ross was part of the research programs at the NIAID HIV research clinic and the Vaccine Research Center. His areas of interest are HIV care, orthopedic infections and general Infectious Diseases. Learn more at idmaryland.com. Dr. Ross is rated as an Experienced provider by MediFind in the treatment of Sepsis. His top areas of expertise are Sepsis, Infectious Arthritis, Lymphangitis, and Osteomyelitis.

Dr. Christine Durand, associate professor of medicine and oncology and member of the Johns Hopkins Kimmel Cancer Center, is involved in clinical and translational research focused on individuals infected with HIV and hepatitis C virus who require cancer and transplant therapies. Her current research efforts include looking at outcomes of hepatitis C treatment after solid organ transplant, the potential use of organs from HIV-infected donors for HIV-infected solid organ transplant candidates, and HIV cure strategies including bone marrow transplantation. Dr. Durand is rated as an Experienced provider by MediFind in the treatment of Sepsis. Her top areas of expertise are HIV/AIDS, Hepatitis C, Hepatitis, Tissue Biopsy, and Nephrectomy.

Dr. Christopher Hoffmann's primary appointment is in the Department of Medicine, Division of Infectious Diseases. His areas of clinical expertise include HIV/AIDS and infectious diseases. Dr. Hoffmann earned his M.D. and M.P.H. from Oregon Health and Sciences University. He completed his residency at Johns Hopkins and performed a fellowship in infectious diseases at Johns Hopkins. His research interests include care delivery and care utilization, in low- and middle-income settings (mostly Africa), and clinical management of HIV and TB. Dr. Hoffmann is a member of several professional organizations, including the American College of Physicians and the Infectious Diseases Society of America. Dr. Hoffmann is rated as an Experienced provider by MediFind in the treatment of Sepsis. His top areas of expertise are HIV/AIDS, Myelitis, AIDS Dysmorphic Syndrome, and AIDS Dementia Complex.

Mark Sulkowski, MD, is a Professor of Medicine at the Johns Hopkins University School of Medicine and the Director of the Division of Infectious Diseases at Johns Hopkins Bayview Medical Center. He also serves as the Medical Director of the Viral Hepatitis Center in the Divisions of Infectious Diseases and Gastroenterology/Hepatology in the Department of Medicine and is the Senior Associate Dean for Clinical Trials. He received his MD from Temple University School of Medicine, Philadelphia, PA (1992), pursued training in Internal Medicine at Duke University School of Medicine, Durham, NC (1995) and completed his Fellowship in Infectious Diseases (1998) at the Johns Hopkins University School of Medicine. Prof. Sulkowski has been the principal investigator for more than 120 clinical trials related to the management of viral hepatitis B and C in persons with and without HIV co-infection. He was the global principal investigator for more than a dozen trials, including the largest clinical trial of agents for the treatment of hepatitis C (New England Journal of Medicine, 2009) and the vanguard study of combination therapy with direct inhibitors of the HCV NS5A and NS5B non-structural proteins (New England Journal of Medicine, 2014). He is the past-chair of the Hepatitis Transformative Sciences Group of the National Institute of Health-funded adult AIDS Clinical Trials Group (ACTG) where he led translational studies of liver disease, namely hepatitis B and C virus. He is an elected member of the American Society for Clinical Investigation (2011) and the American Association of Physicians (2017). Prof. Sulkowski is a member of numerous professional societies including the American Association for the Study of Liver Diseases (AASLD), the European Association for the Study of the Liver (EASL), and the Infectious Diseases Society of America (IDSA). With more than 300 peer-reviewed articles, he is widely published with works in Annals of Internal Medicine, New England Journal of Medicine, JAMA, Clinical Infectious Diseases, Journal of Hepatology, and Hepatology. In 2017, 2018 and 2019, he was named as a Highly Cited Researcher (Clarivate Analytics) defined as the being in the top 1% of global researchers in 21 fields of the sciences and social sciences based on the number of citations for papers. As an invited lecturer, he has been frequently invited to present at major national and international medical congresses and has educated learners in more than 25 countries. Dr. Sulkowski is rated as an Experienced provider by MediFind in the treatment of Sepsis. His top areas of expertise are Hepatitis C, Hepatitis, HIV/AIDS, and Hepatitis B.

Dr. Andrea L. Cox is a professor of Internal Medicine at the Johns Hopkins University School of Medicine in the Division of Infectious Diseases and is a member of the Johns Hopkins Kimmel Cancer Center. She holds joint appointments in Oncology and at the Johns Hopkins Bloomberg School of Public Health, in Molecular Microbiology and Immunology. She is an internationally recognized leader in studies of immune responses in immunocompetent and immunocompromised patient populations to viral infections and vaccines against them, including SARS-Co-V-2 (the virus that causes COVID-19), HIV, hepatitis B virus (HBV) and hepatitis C virus (HCV). Dr. Cox earned her Ph.D. in chemistry from the University of Virginia, where she characterized peptides that drive T cell responses. She then earned her M.D. and completed internal medicine residency and infectious disease fellowship training at Johns Hopkins. She leads the largest prospective cohort study of acute HCV infection, designed to enable detailed molecular analysis of HCV transmission, host immune responses, and virus sequence evolution. She co-led the first prophylactic HCV vaccine trial in individuals at risk of HCV infection. She leads a multidisciplinary international team investigating HCV-specific immune responses to improve vaccine development against HCV, is the lead immunologist on a clinical trial of HBV vaccines in people living with HIV, and co-leads a large team investigating immune responses to COVID-19 infection and vaccines. In addition to her research on viral infections and vaccines, Dr. Cox is actively involved in clinical care of patients with HCV, HIV, and HBV infections. Dr. Cox serves as the director of the Medical Scientist Training Program. A teacher, advisor, and mentor of physician-scientists and scientists, Dr. Cox mentors Ph.D. students in the Johns Hopkins Cellular and Molecular Medicine, Molecular Microbiology and Immunology, and the Immunology graduate training programs. Dr. Cox is rated as an Experienced provider by MediFind in the treatment of Sepsis. Her top areas of expertise are Hepatitis C, Hepatitis, COVID-19, and HIV/AIDS.

Selvi Rajagopal, MD, MPH is a diplomat of the American Board of Obesity Medicine. She specializes in medical weight management to prevent and treat chronic disease beginning in late adolescence through adulthood. In her clinical practice at the Johns Hopkins Healthful Eating, Activity and Weight Program, she works with individuals to implement a holistic approach to achieve their health goals through sustainable weight loss and weight maintenance, incorporating key elements of nutrition, exercise, mental health and medication management. Beyond her clinical role, Dr. Rajagopal is engaged in medical student and resident education within Obesity Medicine. Her research and public health interests include the improvement of health and nutrition literacy and food environment policy reform as strategies to reduce chronic disease burden among low-income populations across the age spectrum. Dr. Rajagopal received her Doctor of Medicine degree from George Washington University School of Medicine in Washington, DC. She completed a combined training in Internal Medicine and Pediatrics at Baylor College of Medicine in Houston, Texas. Following residency, she worked as a Medicine-Pediatrics hospitalist prior to joining the combined General Preventive Medicine Residency-Masters in Public Health Program at the Johns Hopkins University Bloomberg School of Public Health in 2018 to pursue her interests in population health and chronic disease prevention. She pursued additional clinical training in weight management at the Johns Hopkins Digestive Weight Loss Center during her Preventive Medicine residency and has since joined clinical faculty within the Division of General Internal Medicine at the Johns Hopkins University School of Medicine. Dr. Rajagopal is rated as an Experienced provider by MediFind in the treatment of Sepsis. Her top areas of expertise are Obesity, Sepsis, Neurotoxicity Syndromes, and Balloon Sinuplasty.

Dr. Paul Auwaerter is a professor of medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include Lyme disease, Epstein-Barr virus and fever of unknown origin. Dr. Auwaerter serves as the clinical director of the Division of Infectious Diseases. He is also the director of the Fisher Center for Environmental Infectious Diseases and the chief medical officer of the Point of Care-Information Technology (POC-IT) Center. He earned his M.D. from the Columbia University College of Physicians and Surgeons. His research interests include tick-borne diseases and point of care information technology. Dr. Auwaerter serves on the Clinical Compensation Subcommittee for the Johns Hopkins Department of Medicine. He was recognized with a Healthnetworks Service Excellence Award in 2014. He is a member of the American Society of Microbiology and the Infectious Diseases Society of America. Dr. Auwaerter is rated as an Experienced provider by MediFind in the treatment of Sepsis. His top areas of expertise are Lyme Disease, Infectious Myocarditis, Babesiosis, and Osteomyelitis.

Ulrike Kirsten Buchwald is an infectious diseases and HIV physician who attended Medical School in Germany and completed training in internal medicine residency and infectious diseases at New York University. In 2010, she joined the University of Maryland School of Medicine, Division of Infectious Diseases and the Institute of Human Virology. Dr. Buchwald received training in anal cancer screening and high-resolution anoscopy (HRA) and started a dedicated anal cancer screening clinic known as the Anal Lesion Evaluation Research Treatment (ALERT) clinic at the University of Maryland. She was the director of the ALERT clinic and in 2017 co-founded the Maryland Consortium for Anal Cancer Screening (MCACS) with Dr. Joyce Jones, Johns Hopkins Department of Medicine, and colleagues from the Department of Colorectal Surgery, to strengthen clinical care and research for HPV-related anal disease. She joined the Division of Gastroenterology and Hepatology at Johns Hopkins in 2019 to build a multi-disciplinary team dedicated to anal cancer screening, and to increase access to high-resolution anoscopy services and HPV-related anal dysplasia treatment for high-risk patients in Baltimore and the region. Recent News Articles and Media Coverage Making Anal Cancer Screening a Priority for High-Risk Patients Hopkins Medicine. Dr. Buchwald is rated as an Experienced provider by MediFind in the treatment of Sepsis. Her top areas of expertise are Strep Throat, Chronic Graft Versus Host Disease (cGvHD), Pneumonia, and Meningitis.

Dr. Michael T. Melia is an Associate Professor of medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include general infectious diseases, HIV and Lyme disease. He serves as the Director of the Infectious Diseases Fellowship Program. After receiving his medical degree from the Georgetown University School of Medicine, Dr. Melia completed his internal medicine residency, infectious diseases fellowship, and chief medical residency at the Beth Israel Deaconess Medical Center. He joined the Johns Hopkins faculty in 2008. Dr. Melia's academic and research interests center around medical education and coaching in medicine. He is the current Chair of the IDSA Medical Education Community of Practice and is a past Chair of the IDSA Training Program Directors' Committee. In 2015, Dr. Melia was recognized with the Outstanding Achievement in Teaching Award from the Institute for Excellence in Education at the Johns Hopkins University School of Medicine. Dr. Melia is rated as an Experienced provider by MediFind in the treatment of Sepsis. His top areas of expertise are Lyme Disease, Hepatitis C, Allergic Bronchopulmonary Aspergillosis, and HIV/AIDS.

Mohammed Kiddugavu is an Infectious Disease provider in Randallstown, Maryland. Dr. Kiddugavu is rated as an Experienced provider by MediFind in the treatment of Sepsis. His top areas of expertise are End-Stage Renal Disease (ESRD), Sepsis, Myelitis, AIDS Dementia Complex, and Endoscopy. Dr. Kiddugavu is currently accepting new patients.

Radhika Pilla is a primary care provider, practicing in Internal Medicine in Randallstown, Maryland. Dr. Pilla is rated as an Experienced provider by MediFind in the treatment of Sepsis. Her top areas of expertise are Necrosis, Renovascular Hypertension, Cellulitis, Gastrostomy, and Colonoscopy. Dr. Pilla is currently accepting new patients.